Andrew Reardon - 30 Jun 2025 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
30 Jun 2025
Net transactions value
+$21,221
Form type
4
Filing time
02 Jul 2025, 19:32:33 UTC
Previous filing
24 Jun 2025
Next filing
12 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reardon Andrew CLO & Secretary 555 HERITAGE DRIVE, SUITE 200, JUPITER /s/ Andrew Reardon 02 Jul 2025 0001950232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Other $21,221 +233 +0.73% $91.08 32,136 30 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).